Attys Seek $113M In Fees From Glumetza Buyers' $454M Deal
By Dave Simpson · December 2, 2021, 6:52 PM EST
A class of direct Glumetza buyers who scored $454 million in settlements that will end several claims that drugmakers plotted to delay the generic version of the blockbuster diabetes drug asked...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login